121 related articles for article (PubMed ID: 3330516)
1. The metabolism and fate of closantel (Flukiver) in sheep and cattle.
Michiels M; Meuldermans W; Heykants J
Drug Metab Rev; 1987; 18(2-3):235-51. PubMed ID: 3330516
[TBL] [Abstract][Full Text] [Related]
2. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
[TBL] [Abstract][Full Text] [Related]
3. Flukicidal action of closantel against immature and mature Fasciola hepatica in experimentally infected rats and sheep.
Maes L; Lauwers H; Deckers W; Vanparijs O
Res Vet Sci; 1988 Mar; 44(2):229-32. PubMed ID: 3387677
[TBL] [Abstract][Full Text] [Related]
4. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
[TBL] [Abstract][Full Text] [Related]
5. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of a novel closantel/ivermectin injection in cattle.
Cromie L; Ferry M; Couper A; Fields C; Taylor SM
J Vet Pharmacol Ther; 2006 Jun; 29(3):205-11. PubMed ID: 16669865
[TBL] [Abstract][Full Text] [Related]
7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
[TBL] [Abstract][Full Text] [Related]
8. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
9. The effect of feed intake level on the pharmacokinetic disposition of closantel in sheep.
Hennessy DR; Ali DN
Int J Parasitol; 1997 Sep; 27(9):1081-6. PubMed ID: 9363491
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 2nd communication: distribution and transfer into the fetus and milk after a single intravenous administration and pharmacokinetics and enzyme induction after repeated intravenous administration to rats.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):114-27. PubMed ID: 8720299
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
12. The pharmacodynamics of the flukicidal salicylanilides, rafoxanide, closantel and oxyclosanide.
Mohammed-Ali NA; Bogan JA
J Vet Pharmacol Ther; 1987 Jun; 10(2):127-33. PubMed ID: 3612940
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
Okuyama Y; Momota K; Morino A
Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
[TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetic disposition of closantel in sheep and goats.
Hennessy DR; Sangster NC; Steel JW; Collins GH
J Vet Pharmacol Ther; 1993 Sep; 16(3):254-60. PubMed ID: 8230396
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
[TBL] [Abstract][Full Text] [Related]
16. Activity of closantel against experimentally induced Fascioloides magna infection in sheep.
Stromberg BE; Schlotthauer JC; Seibert BP; Conboy GA; Newcomb KM
Am J Vet Res; 1985 Dec; 46(12):2527-9. PubMed ID: 4083587
[TBL] [Abstract][Full Text] [Related]
17. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
18. Intravascular plasma disposition and salivary secretion of closantel and rafoxanide in sheep.
Swan GE; Koeleman HA; Steyn HS; Mülders MS
J S Afr Vet Assoc; 1999 Jun; 70(2):75-9. PubMed ID: 10855826
[TBL] [Abstract][Full Text] [Related]
19. Slight resistance to the residual effect of closantel in a field strain of Haemonchus contortus which showed an increased resistance after one selection in the laboratory.
Van Wyk JA; Gerber HM; Alves RM
Onderstepoort J Vet Res; 1982 Dec; 49(4):257-61. PubMed ID: 6764253
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
